Regeneron Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Regeneron Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: January 21, 2018, 9:34 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: January 21, 2018, 9:34 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: January 20, 2018, 9:17 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: January 20, 2018, 9:17 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: January 20, 2018, 9:17 am

Viewing page 1 of 89|Next Page

  Newsfeed | Subscribe  

Get the full research report on RARE for free by clicking below at: Tarrytown, New York headquartered Regeneron Pharmaceuticals Inc.'s stock climbed 1.04%, closing the day at $374.07 with a total trading volume of 738,804 shares. The Company's sha...
Posted: January 18, 2018, 5:23 am
WallStEquities.com evaluates Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Seattle Genetics Inc. (NASDAQ: SGEN), and Sangamo Therapeutics Inc. (NASDAQ: SGMO). Biotech companies are engaged in the R&D...
Posted: January 18, 2018, 4:34 am
Regeneron Pharmaceuticals Inc.: "No. Regeneron is a buy, and a lot of people are giving up on this stock. It's got so [many] irons in the fire, it's crazy." Floor & Decor Holdings Inc.: "I say you buy, buy, buy because both floor and décor are red...
Posted: January 12, 2018, 6:49 pm
A new collaboration between Regeneron Pharmaceuticals Inc. and five other drugmakers aims to speed up the generation of genetic exome sequence data from the 500,000 participants of the UK Biobank, an initiative that could support advances in the ...
Posted: January 10, 2018, 7:22 am
Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that they will expand their investment for the development of the programmed cell death protein 1 (PD-1) antibody, cemiplimab, in oncology and label expansion of the IL-4/IL-13 ...
Posted: January 9, 2018, 7:44 am

Viewing page 1 of 2|Next Page